{"filing":{"accession_number":"0001294133-26-000021","cik":"0001294133","ticker":"INGN","company_name":"Inogen Inc","form":"8-K","filing_date":"2026-06-11","report_date":null,"primary_document":"ingn-20260605.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1294133/000129413326000021/ingn-20260605.htm"},"events":[{"id":5422,"run_id":4748,"accession_number":"0001294133-26-000021","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Inogen held its 2026 Annual Meeting of Stockholders and disclosed complete voting results on five matters: election of Class III directors (Boehnlein and Sahney), ratification of Deloitte \u0026 Touche LLP as independent auditor, advisory vote on executive compensation, approval of the Amended and Restated 2023 Equity Incentive Plan with 750,000 additional shares, and a failed amendment to declassify the Board.","company_name":"Inogen Inc","ticker":"INGN","filing_date":"2026-06-11","form":"8-K","submitted_at":null,"items":[{"id":6363,"accession_number":"0001294133-26-000021","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an Amended and Restated 2023 Equity Incentive Plan with an increase of 750,000 shares available for issuance. This is a compensatory arrangement affecting equity grants to officers and directors. While shareholder approval was obtained, the material event is the plan amendment itself and its impact on future executive compensation capacity, not the voting results per se.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:33:56.855332+00:00","company_name":"","ticker":null,"filing_date":""},{"id":6364,"accession_number":"0001294133-26-000021","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 filing discloses the complete results of Inogen's 2026 Annual Meeting of Stockholders, including votes on five matters: election of Class III directors (Boehnlein and Sahney), ratification of Deloitte \u0026 Touche LLP as independent auditor, advisory vote on executive compensation, approval of the Amended and Restated 2023 Equity Incentive Plan, and a failed amendment to declassify the Board. The disclosure includes vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal, which is the standard format for shareholder vote results under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:33:56.855332+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6363,"accession_number":"0001294133-26-000021","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an Amended and Restated 2023 Equity Incentive Plan with an increase of 750,000 shares available for issuance. This is a compensatory arrangement affecting equity grants to officers and directors. While shareholder approval was obtained, the material event is the plan amendment itself and its impact on future executive compensation capacity, not the voting results per se.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:33:56.855332+00:00","company_name":"Inogen Inc","ticker":"INGN","filing_date":"2026-06-11"},{"id":6364,"accession_number":"0001294133-26-000021","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 filing discloses the complete results of Inogen's 2026 Annual Meeting of Stockholders, including votes on five matters: election of Class III directors (Boehnlein and Sahney), ratification of Deloitte \u0026 Touche LLP as independent auditor, advisory vote on executive compensation, approval of the Amended and Restated 2023 Equity Incentive Plan, and a failed amendment to declassify the Board. The disclosure includes vote tallies (For, Against, Abstentions, Broker Non-Votes) for each proposal, which is the standard format for shareholder vote results under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:33:56.855332+00:00","company_name":"Inogen Inc","ticker":"INGN","filing_date":"2026-06-11"}]}